OOIR: Observatory of International Research

Papers

(The H4-Index of Medical Journal of Australia is 29. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Trajectories of depression and anxiety symptoms during the COVID‐19 pandemic in a representative Australian adult cohort	86
Outcomes for patients with COVID‐19 admitted to Australian intensive care units during the first four months of the pandemic	67
Electronic cigarettes and health outcomes: umbrella and systematic review of the global evidence	62
The 2020 special report of the MJA–Lancet Countdown on health and climate change: lessons learnt from Australia’s “Black Summer”	62
Modelling the impact of relaxing COVID ‐19 control measures during a period of low viral transmission	60
The 2020 Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease	57
Effectiveness of COVID‐19 vaccines: findings from real world studies	57
Communicating with patients and the public about COVID‐19 vaccine safety: recommendations from the Collaboration on Social Science and Immunisation	48
The efficacy and safety of paracetamol for pain relief: an overview of systematic reviews	48
Failures of quarantine systems for preventing COVID‐19 outbreaks in Australia and New Zealand	47
Potential indirect impacts of the COVID‐19 pandemic on children: a narrative review using a community child health lens	42
New Australian guidelines for the treatment of alcohol problems: an overview of recommendations	42
The prevalence and impact of unprofessional behaviour among hospital workers: a survey in seven Australian hospitals	41
The 2021 report of theMJA–LancetCountdown on health and climate change: Australia increasingly out on a limb	40
Persistent symptoms up to four months after community and hospital‐managed SARS‐CoV‐2 infection	40
Australian recommendations for the management of hepatocellular carcinoma: a consensus statement	39
Australia in 2030: what is our path to health for all?	37
Detecting primary aldosteronism in Australian primary care: a prospective study	37
The CANBACK trial: a randomised, controlled clinical trial of oral cannabidiol for people presenting to the emergency department with acute low back pain	37
The readability of official public health information on COVID‐19	35
High value health care is low carbon health care	35
Decline in cancer pathology notifications during the 2020 COVID‐19‐related restrictions in Victoria	32
Australian and New Zealand approach to diagnosis and management of vaccine‐induced immune thrombosis and thrombocytopenia	31
Chemical analysis of fresh and aged Australian e‐cigarette liquids	31
Otitis media guidelines for Australian Aboriginal and Torres Strait Islander children: summary of recommendations	31

Social and occupational outcomes for young people who attend early intervention mental health services: a longitudinal study	30
Suicide by young Australians, 2006–2015: a cross‐sectional analysis of national coronial data	30
A hospital‐wide response to multiple outbreaks of COVID ‐19 in health care workers: lessons learned from the field	30
The prevalence of child maltreatment in Australia: findings from a national survey	30
Modern paradigms for prostate cancer detection and management	29
Late mortality in people with cancer: a population‐based Australian study	29
People in intensive care with COVID ‐19: demographic and clinical features during the first, second, and third pandemic waves in Australia	29